CAPRA Symposium 2017, SPharm will be present!
In collaboration with the International Generic Drug Regulators Programme (IGDRP) and Health Canada, CAPRA, will host a one day symposium. It will be an ideal opportunity to hear from key international regulators and industry representatives on drivers and the progress of the IGDRP activities and on other initiatives facing regulators and the pharmaceutical industry.
The Canadian Association of Professionals in Regulatory Affairs (CAPRA) is a non-profit organization that serves the pharmaceutical, biologics, medical device, cosmetic and natural health product industries in Canada.
With over 20 years of consistent and successful results, SPharm has become one of the leading Drug Regulatory Advisory firms in Canada. Drug companies from around the world count on SPharm to help them navigate the drug (and other health products) review & approval process in Canada.
Après plus de 20 ans de résultats et de succès constants, SPharm est devenue une entreprise de services de référence au Canada en stratégie de développement de médicaments et affaires réglementaires. Des compagnies pharmaceutiques à travers le monde comptent sur SPharm pour faciliter le processus d’homologation de leurs médicaments (et autres produits de santé) au Canada.
Canadian Association of Professionals in Regulatory Affairs, canadian drug approval process, capra symposium, clinical trial approval canada, drug approval consultant canada, drug approval consultants canada, drug approval process in canada, drug regulatory consultant canada, drug regulatory process canada, health canada drug approval, Medical Device Canada, Medical Devices Licence Applications
CAPRA Symposium 20172017-06-092018-02-28https://spharm-inc.com/wp-content/uploads/2017/12/spharm-logo.pngSPharm - Drug Regulatory Expertshttps://spharm-inc.com/wp-content/uploads/2017/06/capra-symposium.png200px200px
With over 20 years of consistent and successful results, SPharm has become one of the leading Drug Regulatory Advisory firms in Canada. Drug companies from around the world count on SPharm to help them navigate the drug (and other health products) review & approval process in Canada.
Après plus de 20 ans de résultats et de succès constants, SPharm est devenue une entreprise de services de référence au Canada en stratégie de développement de médicaments et affaires réglementaires. Des compagnies pharmaceutiques à travers le monde comptent sur SPharm pour faciliter le processus d'homologation de leurs médicaments (et autres produits de santé) au Canada.